All filters
Videos
Management of TB and HIV Infection - Daria Podlekareva, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Videos
Switching to Second-Line HIV Therapy - Pavel Khaykin, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Videos
Integrated Testing for HIV, Hepatitis and STIs - Dorthe Raben, MSc
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Videos
PrEP and STI Testing in CEE: What are the Barriers, What Works? - Milosz Parczewski, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Videos
Management of HIV/HCV Co-Infection in Young Women - Ekaterina Boeva, MD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Videos
EECA: Are We Lagging Behind? - Sergey Golovin
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Videos
Access to Key Populations - Mojca Maticic, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Videos
Access to Quality-Assured (WHO Prequalified) Generic Medicines in the Region - Liudmyla Maistat
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Videos
Epidemiology of Viral Hepatitis Infection and Treatment in the CEE Countries - Milosz Parczewski, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Videos
Feasibility and Acceptability of HCV Self-Testing - Elena Ivanova, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Videos
Epidemiology of HIV Infection and Treatment in the CEE Countries - Anca Streinu-Cercel, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2019
Slidesets
Oxazolidinones for TB: Current Status and Future Prospects - Lawrence Geiter
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Evaluating Hepatotoxicity of Bedaquiline Treatment in Multi-Drug Resistant Tuberculosis Patients - Lénaïg Tanneau
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Relationship Between Plasma and Intracellular Concentrations of Bedaquiline and its M2 Metabolite in South African Patients with Drug-Resistant TB - Precious Ngwalero
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Pharmacokinetics and Early Bactericidal Activity of Meropenem (with Amoxicillin/Clavulanate), With and Without Rifampicin, for Drug-Susceptible TB - Ahmed Aliyu Abulfathi
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Co-Administration of Pretomanid with Rifampin or Rifabutin Among Patients with Pulmonary TB: Interim PK Results from “Assessing Pretomanid for Tuberculosis” (APT) Trial - Elisa Ignatius
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Exposures to First-Line Drugs in African and Indian Children with Drug-Susceptible Tuberculosis using Novel Fixed-Dose-Combination Tablets at WHO Dosing Recommendation in the SHINE Trial - Chishala Chabala
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Ethionamide Population Pharmacokinetic Model and Monte Carlo Simulation in Patients with Multidrug-Resistant Tuberculosis - Charles Peloquin
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Can Longitudinal PKPD Biomarkers be used to Forecast Treatment Outcome Instead of M2 Conversion? A Population Pharmacokinetic-Pharmacodynamic Analysis in Drug Sensitive Pulmonary Tuberculosis - Frank Kloprogge
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Pharmacokinetic-Pharmacodynamic Analysis in TB Drug Development and the Role of the WHO - Ernesto Jaramillo
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
PK-PD of Isoniazid Given at Different Doses Among Patients with MDR-TB with INH Resistance Mediated by inhA Mutations: Modeling Results from ACTG A5312 - Kamunkhwala Gausi
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019
Slidesets
Population Pharmacokinetics of Linezolid in TB Patients: Dosing Regimens Simulation and Target Attainment Analysis - Charles Peloquin
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2019